Neurological manifestations of SARS-CoV-2 infections: towards quantum dots based management approaches

References

• Worldometer S. Covid-19 coronavirus pandemic: Worldometer, 2022.
   Google Scholar
• Ali I, Alharbi OM. COVID-19: Disease, management, treatment, and social impact. Sci Total Environ. 2020;728:138861.
   PubMed Web of Science ®Google Scholar
• Hossain MU, Bhattacharjee A, Emon MTH, et al. Recognition of plausible therapeutic agents to combat COVID-19: an omics data based combined approach. Gene. 2021;771:145368.
   PubMed Web of Science ®Google Scholar
• Almasi F, Mohammadipanah F. Hypothetical targets and plausible drugs of coronavirus infection caused by SARS-CoV-2. Transbound Emerg Dis. 2021;68(2):318–332. Mar
   PubMed Web of Science ®Google Scholar
• Zhou Z, Qiu Y, Ge X. The taxonomy, host range and pathogenicity of coronaviruses and other viruses in the nidovirales order. Anim Dis. 2021;1(1):5.
   PubMedGoogle Scholar
• Chen R, Fu J, Hu J, et al. Identification of the immunodominant neutralizing regions in the spike glycoprotein of porcine deltacoronavirus. Virus Res. 2020;276:197834.
   PubMed Web of Science ®Google Scholar
• Xia X. Domains and functions of spike protein in Sars-Cov-2 in the context of vaccine design. Viruses. 2021;13(1):109.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280. e8.
   PubMed Web of Science ®Google Scholar
• Yadav R, Chaudhary JK, Jain N, et al. Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells. 2021;10(4):821.
   PubMed Web of Science ®Google Scholar
• Guerrero JI, Barragan LA, Martinez JD, et al. Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infect Dis. 2021;21(1):515.
   PubMed Web of Science ®Google Scholar
• Bolay H, Gül A, Baykan B. COVID-19 is a real headache! Headache J Head Face Pain. 2020;60(7):1415–1421.
   PubMed Web of Science ®Google Scholar
• Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020 Jun 1;77(6):683–690.
   PubMed Web of Science ®Google Scholar
• Henss L, Auste A, Schurmann C, et al. The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection. J Gen Virol. 2021;102(4):001574.
   PubMed Web of Science ®Google Scholar
• Sierra-Hidalgo F, Munoz-Rivas N, Torres Rubio P, et al. Large artery ischemic stroke in severe COVID-19. J Neurol. 2020;267(12):3441–3443. Dec
   PubMed Web of Science ®Google Scholar
• Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):e1060–e1070.
   PubMed Web of Science ®Google Scholar
• Kim JW, Abdullayev N, Neuneier J, et al. Post-COVID-19 encephalomyelitis. Neurol Res Pract. 2021;3(1):18.
   PubMedGoogle Scholar
• Jan J-T, Cheng T-JR, Juang Y-P, et al. Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection. Proc Natl Acad Sci USA. 2021;118(5):e2021579118.
   Web of Science ®Google Scholar
• Berger JR, Brandstadter R, Bar-Or A. Bar-Or A. COVID-19 and MS disease-modifying therapies. Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e761. Jul
   PubMed Web of Science ®Google Scholar
• Altshuler DB, Kadiyala P, Nuñez FJ, et al. Prospects of biological and synthetic pharmacotherapies for glioblastoma. Expert Opin Biol Ther. 2020;20(3):305–317.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Sahashi Y, Baba Y, et al. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion. J Neurol Sci. 2020;415:116941.
   PubMed Web of Science ®Google Scholar
• Cariddi LP, Damavandi PT, Carimati F, et al. Reversible encephalopathy syndrome (PRES) in a COVID-19 patient. J Neurol. 2020;267(11):3157–3160.
   PubMed Web of Science ®Google Scholar
• Monti G, Giovannini G, Marudi A, et al. Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19. Seizure. 2020;81:18–20.
   PubMed Web of Science ®Google Scholar
• Lau KK, Yu WC, Chu CM, et al. Possible Central nervous system infection by SARS coronavirus. Emerg Infect Dis. 2004;10(2):342–344. Feb
   PubMed Web of Science ®Google Scholar
• Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle east respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 2014;29:301–306. Dec
   PubMed Web of Science ®Google Scholar
• Hepburn M, Mullaguri N, George P, et al. Acute symptomatic seizures in critically ill patients with COVID-19: is there an association? Neurocrit Care. 2021;34(1):139–143.
   PubMed Web of Science ®Google Scholar
• Pascual-Goñi E, Fortea J, Martínez-Domeño A, et al. COVID-19-associated ophthalmoparesis and hypothalamic involvement. Neurol Neuroimmunol Neuroinflam. 2020;7(5):e823.
   PubMed Web of Science ®Google Scholar
• Ferreira A, Romao TT, Macedo YS, Fellow of the American Academy of Neurology (FAAN), et al. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy. Eur J Neurol. 2020;27(9):1748–1750. Sep
   PubMed Web of Science ®Google Scholar
• Loza AMM, Holroyd KB, Johnson SA, et al. Guillain-Barré syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality. Neurology. 2021;96(22):1052–1054.
   Web of Science ®Google Scholar
• Scheidl E, Canseco DD, Hadji-Naumov A, et al. Guillain-barré syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. J Peripher Nerv Syst. 2020;25(2):204–207.
   PubMed Web of Science ®Google Scholar
• Li Z, Li X, Shen J, et al. Miller fisher syndrome associated with COVID-19: an up-to-date systematic review. Environ Sci Pollut Res Int. 2021 May;28(17):20939–20944.
   PubMed Web of Science ®Google Scholar
• Madia F, Merico B, Primiano G, et al. Acute myopathic quadriplegia in patients with COVID-19 in the intensive care unit. Neurology. 2020;95(11):492–494. Sep 15
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, China Novel Coronavirus Investigating and Research Team, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
   PubMed Web of Science ®Google Scholar
• Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18–22. Jul
   PubMed Web of Science ®Google Scholar
• Iroegbu JD, Ifenatuoha CW, Ijomone OM. Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2. Neurol Sci. 2020;41(6):1329–1337. Jun
   PubMed Web of Science ®Google Scholar
• Burks JS, DeVald BL, Jankovsky LD, et al. Two coronaviruses isolated from Central nervous system tissue of two multiple sclerosis patients. Science. 1980;209(4459):933–934.
   PubMed Web of Science ®Google Scholar
• Li Y, Li H, Fan R, et al. Coronavirus infections in the Central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology. 2016;59(3):163–169.
   PubMed Web of Science ®Google Scholar
• Nilsson A, Edner N, Albert J, et al. Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child. Infect Dis (Lond). 2020;52(6):419–422. Jun
   PubMed Web of Science ®Google Scholar
• Hung EC, Chim SS, Chan PK, et al. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem. 2003;49(12):2108–2109.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhong S, Liu J, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis. 2005;41(8):1089–1096.
   PubMed Web of Science ®Google Scholar
• Ding Y, Wang H, Shen H, et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol. 2003;200(3):282–289.
   PubMed Web of Science ®Google Scholar
• Umapathi T, Kor AC, Venketasubramanian N, et al. Large artery ischaemic stroke in severe acute respiratory syndrome (SARS). J Neurol. 2004;251(10):1227–1231.
   PubMed Web of Science ®Google Scholar
• Tsai LK, Hsieh ST, Chao CC, et al. Neuromuscular disorders in severe acute respiratory syndrome. Arch Neurol. 2004;61(11):1669–1673.
   PubMedGoogle Scholar
• Chao CC, Tsai LK, Chiou YH, et al. Peripheral nerve disease in SARS: report of a case. Neurology. 2003;61(12):1820–1821.
   PubMed Web of Science ®Google Scholar
• Hwang CS. Olfactory neuropathy in severe acute respiratory syndrome: report of a case. Acta Neurol Taiwan. 2006;15(1):26–28.
   PubMedGoogle Scholar
• Leung TW, Wong KS, Hui AC, et al. Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series. Arch Neurol. 2005;62(7):1113–1117.
   PubMedGoogle Scholar
• Bleibtreu A, Bertine M, Bertin C, et al. Focus on Middle east respiratory syndrome coronavirus (MERS-CoV). Med Mal Infect. 2020;50(3):243–251.
   PubMed Web of Science ®Google Scholar
• Arabi YM, Harthi A, Hussein J, et al. Severe neurologic syndrome associated with Middle east respiratory syndrome corona virus (MERS-CoV). Infection. 2015;43(4):495–501. Aug
   PubMed Web of Science ®Google Scholar
• Algahtani H, Subahi A, Shirah B. Neurological complications of Middle east respiratory syndrome coronavirus: a report of two cases and review of the literature. Case Rep Neurol Med. 2016;2016:3502683.
   PubMed Web of Science ®Google Scholar
• Kim JE, Heo JH, Kim HO, et al. Neurological complications during treatment of Middle east respiratory syndrome. J Clin Neurol. 2017;13(3):227–233. Jul
   PubMed Web of Science ®Google Scholar
• Vitalakumar D, Sharma A, Kumar A, et al. Neurological manifestations in COVID-19 patients: a meta-analysis. ACS Chemical Neuroscience. 2021;12(15):2776–2797.
   PubMed Web of Science ®Google Scholar
• Li Z, Liu T, Yang N, et al. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med. 2020;14(5):533–541.
   PubMed Web of Science ®Google Scholar
• Leven Y, Bösel J. Neurological manifestations of COVID-19–an approach to categories of pathology. Neurol Res Pract. 2021;3(1):1–12.
   PubMedGoogle Scholar
• Dorche MS, Huot P, Osherov M, et al. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci. 2020;417:117085.
   PubMed Web of Science ®Google Scholar
• Morgello S. Coronaviruses and the Central nervous system. J Neurovirol. 2020;26(4):459–473. Aug
   PubMed Web of Science ®Google Scholar
• Barichello T, Collodel A, Hasbun R, et al. An overview of the blood-brain barrier. Blood-Brain Barrier. 2019;142:1–8.
   Google Scholar
• Banks WA. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol. 2009;9(Suppl. 1):S3–S5.
   PubMedGoogle Scholar
• Hashimoto Y, Campbell M. Tight junction modulation at the blood-brain barrier: current and future perspectives. Biochim Biophys Acta Biomembr. 2020;1862(9):183298.
   PubMed Web of Science ®Google Scholar
• Profaci CP, Munji RN, Pulido RS, et al. The blood–brain barrier in health and disease: Important unanswered questions. J Experim Med. 2020;217(4):e20190062.
   PubMed Web of Science ®Google Scholar
• Erickson MA, Rhea EM, Knopp RC, et al. Interactions of SARS-CoV-2 with the blood–brain barrier. IJMS. 2021;22(5):2681.
   Google Scholar
• Bohmwald K, Galvez N, Ríos M, et al. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. 2018;12:386.
   PubMed Web of Science ®Google Scholar
• Leda AR, Bertrand L, Andras IE, et al. Selective disruption of the blood–brain barrier by zika virus. Front Microbiol. 2019;10:2158.
   PubMed Web of Science ®Google Scholar
• Bertrand L, Cho HJ, Toborek M. Blood–brain barrier pericytes as a target for HIV-1 infection. Brain. 2019;142(3):502–511.
   Google Scholar
• Crema A, Ponzetto A, Clementi M, et al. Steps and routes of HCV infection: the great promise of new anti-Viral targets. Curr Drug Targets. 2015;16(7):757–770.
   PubMed Web of Science ®Google Scholar
• Suen WW, Prow NA, Hall RA, et al. Mechanism of West Nile virus neuroinvasion: a critical appraisal. Viruses. 2014;6(7):2796–2825. 18
   PubMed Web of Science ®Google Scholar
• Lancet T. Facing up to long COVID. Lancet. 2020;396(10266):1861.
   PubMed Web of Science ®Google Scholar
• Rychert J, Strick D, Bazner S, et al. Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines. AIDS Res Hum Retroviruses. 2010;26(10):1139–1145.
   PubMed Web of Science ®Google Scholar
• Rhea EM, Logsdon AF, Hansen KM, et al. The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice. Nat Neurosci. 2021;24(3):368–378.
   PubMed Web of Science ®Google Scholar
• Tay MZ, Poh CM, Renia L, et al. The Trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363–374.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Erickson MA, Wilson ML, Banks WA. In vitro modeling of blood–brain barrier and interface functions in neuroimmune communication. Fluids Barriers CNS. 2020;17(1):1–16.
   PubMed Web of Science ®Google Scholar
• Lee MH, Perl DP, Nair G, et al. Microvascular injury in the brains of patients with covid-19. N Engl J Med. 2021;384(5):481–483.
   PubMed Web of Science ®Google Scholar
• Grant MC, Geoghegan L, Arbyn M, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and Meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15(6):e0234765.
   PubMed Web of Science ®Google Scholar
• Eskilsson A, Mirrasekhian E, Dufour S, et al. Immune-induced fever is mediated by IL-6 receptors on brain endothelial cells coupled to STAT3-dependent induction of brain endothelial prostaglandin synthesis. J Neurosci. 2014;34(48):15957–15961.
   PubMed Web of Science ®Google Scholar
• Fritz M, Klawonn AM, Nilsson A, et al. Prostaglandin-dependent modulation of dopaminergic neurotransmission elicits inflammation-induced aversion in mice. J Clin Invest. 2016;126(2):695–705. Feb
   PubMed Web of Science ®Google Scholar
• Llorens S, Nava E, Munoz-Lopez M, et al. Neurological symptoms of COVID-19: the zonulin hypothesis. Front Immunol. 2021;12:665300.
   PubMed Web of Science ®Google Scholar
• Merrill JT, Erkan D, Winakur J, et al. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020;16(10):581–589.
   PubMed Web of Science ®Google Scholar
• Sharma S, Pavuluri S, Srinivasan K, et al. Thrombotic microangiopathy in a patient with COVID-19 infection and metastatic cholangiocarcinoma. J Hematol. 2021;10(2):83–88. Apr
   PubMedGoogle Scholar
• Sun X, Yin Y, Kong L, et al. The effect of propofol on hypoxia-modulated expression of heat shock proteins: potential mechanism in modulating blood–brain barrier permeability. Mol Cell Biochem. 2019;462(1-2):85–96.
   PubMed Web of Science ®Google Scholar
• Colgan SP, Furuta GT, Taylor CT. Hypoxia and innate immunity: Keeping up with the HIFsters. Annu Rev Immunol. 2020;38:341–363.
   PubMed Web of Science ®Google Scholar
• Baig AM, Khaleeq A, Ali U, et al. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995–998.
   PubMed Web of Science ®Google Scholar
• Ou X, Liu Y, Lei X, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11(1):1620.
   PubMed Web of Science ®Google Scholar
• Coutard B, Valle C, de Lamballerie X, et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020;176:104742. Apr
   PubMed Web of Science ®Google Scholar
• Daly JL, Simonetti B, Klein K, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370(6518):861–865.
   PubMed Web of Science ®Google Scholar
• Wang K, Chen W, Zhang Z, et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Sig Transduct Target Ther. 2020;5(1):1–10.
   PubMed Web of Science ®Google Scholar
• Paniz-Mondolfi A, Bryce C, Grimes Z, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020;92(7):699–702. Jul
   PubMed Web of Science ®Google Scholar
• Sungnak W, Huang N, Becavin C, HCA Lung Biological Network, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681–687.
   PubMed Web of Science ®Google Scholar
• Baig AM, Sanders EC. Potential neuroinvasive pathways of SARS-CoV-2: Deciphering the spectrum of neurological deficit seen in coronavirus disease-2019 (COVID-19). J Med Virol. 2020;92(10):1845–1857.
   PubMed Web of Science ®Google Scholar
• Netland J, Meyerholz DK, Moore S, et al. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264–7275. Aug
   PubMed Web of Science ®Google Scholar
• Desforges M, Le Coupanec A, Dubeau P, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the Central nervous system? Viruses. 2019;12(1):14.
   PubMed Web of Science ®Google Scholar
• Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of Central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168–175.
   PubMed Web of Science ®Google Scholar
• Sia SF, Yan LM, Chin AWH, et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583(7818):834–838. Jul
   PubMed Web of Science ®Google Scholar
• Dey J, Alam MT, Chandra S, et al. Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain. J Med Virol. 2021;93(3):1296–1303.
   PubMed Web of Science ®Google Scholar
• Xiao F, Tang M, Zheng X, et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831–1833 e3.
   PubMed Web of Science ®Google Scholar
• Cabirac GF, Soike KF, Butunoi C, et al. Coronavirus JHM OMP1 pathogenesis in owl monkey CNS and coronavirus infection of owl monkey CNS via peripheral routes. In Coronaviruses. Boston, MA: Springer; 1994. p. 347–352.
   Google Scholar
• Hocke AC, Becher A, Knepper J, et al. Emerging human Middle east respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs. Am J Respir Crit Care Med. 2013;188(7):882–886.
   PubMed Web of Science ®Google Scholar
• Swanson IP, McGavern DB. Viral diseases of the Central nervous system. Curr Opin Virol. 2015;11:44–54.
   PubMed Web of Science ®Google Scholar
• Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415–424.
   PubMed Web of Science ®Google Scholar
• Bergmann CC, Lane TE, Stohlman SA. Coronavirus infection of the Central nervous system: host–virus stand-off. Nat Rev Microbiol. 2006;4(2):121–132.
   PubMed Web of Science ®Google Scholar
• Desforges M, Miletti TC, Gagnon M, et al. Activation of human monocytes after infection by human coronavirus 229E. Virus Res. 2007;130(1–2):228–240.
   PubMed Web of Science ®Google Scholar
• Feng Z, Diao B, Wang R, et al. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes. Preprint MedRxiv. 2020. https://doi.org/10.1101/2020.03.27.20045427.
   Google Scholar
• Amraei R, Yin W, Napoleon MA, et al. CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2. ACS Cent Sci. 2021;7(7):1156–1165.
   PubMed Web of Science ®Google Scholar
• Yan C, Hu X, Guan P, et al. Highly biocompatible graphene quantum dots: green synthesis, toxicity comparison and fluorescence imaging. J Mater Sci. 2020;55(3):1198–1215.
   Web of Science ®Google Scholar
• Shaker B, Yu M-S, Song JS, et al. LightBBB: computational prediction model of blood–brain-barrier penetration based on LightGBM. Bioinformatics. 2021;37(8):1135–1139.
   PubMed Web of Science ®Google Scholar
• Gkountas AA, Polychronopoulos ND, Sofiadis GN, et al. Simulation of magnetic nanoparticles crossing through a simplified blood-brain barrier model for glioblastoma multiforme treatment. Comput Methods Programs Biomed. 2021;212:106477.
   PubMed Web of Science ®Google Scholar
• Salatin S. Nanocarriers for successful drug delivery across blood-brain barrier. J Experim Clin Neurosci. 2020;7(2):1–7.
   Google Scholar
• Ding S, Khan AI, Cai X, et al. Overcoming blood–brain barrier transport: advances in nanoparticle-based drug delivery strategies. Mater Today. 2020;37:112–125.
   Web of Science ®Google Scholar
• Liu DZ, Cheng Y, Cai RQ, et al. The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle. Nanomedicine. 2018;14(3):991–1003. Apr
   PubMed Web of Science ®Google Scholar
• Dixit S, Novak T, Miller K, et al. Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors. Nanoscale. 2015;7;7(5):1782–1790. Feb
   Web of Science ®Google Scholar
• Jiang W, Xie H, Ghoorah D, et al. Conjugation of functionalized SPIONs with transferrin for targeting and imaging brain glial tumors in rat model. PLoS One. 2012;7(5):e37376.
   PubMed Web of Science ®Google Scholar
• Li S, Peng Z, Dallman J, et al. Crossing the blood–brain–barrier with transferrin conjugated carbon dots: a zebrafish model study. Colloids Surf B Biointerfaces. 2016;145:251–256.
   PubMed Web of Science ®Google Scholar
• Seven ES, Seven YB, Zhou Y, et al. Crossing the blood–brain barrier with carbon dots: uptake mechanism and in vivo cargo delivery. Nanoscale Adv. 2021;3(13):3942–3953.
   PubMed Web of Science ®Google Scholar
• Kumari S, Ahsan SM, Kumar JM, et al. Overcoming blood brain barrier with a dual purpose temozolomide loaded lactoferrin nanoparticles for combating glioma (SERP-17-12433). Sci Rep. 2017;7(1):6602.
   PubMedGoogle Scholar
• Kumar P, Lakshmi YS, Golla K, et al. Improved safety, bioavailability and pharmacokinetics of zidovudine through lactoferrin nanoparticles during oral administration in rats. PLoS One. 2015;10(10):e0140399.
   PubMed Web of Science ®Google Scholar
• Kang T, Jiang M, Jiang D, et al. Enhancing glioblastoma-specific penetration by functionalization of nanoparticles with an iron-mimic peptide targeting transferrin/transferrin receptor complex. Mol Pharm. 2015;12(8):2947–2961.
   PubMedGoogle Scholar
• Mitchell MJ, Billingsley MM, Haley RM, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–124. Feb
   PubMed Web of Science ®Google Scholar
• Gour A, Ramteke S, Jain NK. Pharmaceutical applications of quantum dots. AAPS PharmSciTech. 2021;22(7):233. Sep 2
   PubMed Web of Science ®Google Scholar
• AbouElhamd AR, Al-Sallal KA, Hassan A. Review of core/shell quantum dots technology integrated into building’s glazing. Energies. 2019;12(6):1058.
   Web of Science ®Google Scholar
• Abdellatif AA, Younis MA, Alsharidah M, et al. Biomedical applications of quantum dots: overview, challenges, and clinical potential. Int J Nanomedicine. 2022;17:1951–1970.
   PubMed Web of Science ®Google Scholar
• Zor E, Mollarasouli F, Karadurmus L, et al. Carbon dots in the detection of pathogenic bacteria and viruses. Crit Rev Anal Chem. 2022;May 9:1–29.
   PubMed Web of Science ®Google Scholar
• Sahoo S, Nayak A, Gadnayak A, et al. Quantum dots enabled point-of-care diagnostics: a new dimension to the nanodiagnosis. In Advanced nanomaterials for point of care diagnosis and therapy. Netherlands: Elsevier; 2022. p. 43–52.
   Google Scholar
• Wu F, Mao M, Liu Q, et al. Ultra sensitive detection of influenza a virus based on cdse/zns quantum dots immunoassay. SOJ Biochem. 2016;2(3):2–6.
   Google Scholar
• Ahamed HA, Mohamed MJ, Arunachalam KD, et al. Effects of azomite enriched diet on gonadal steroid hormone levels and milt quality indices in oreochromis mossambicus. Aquacult Rep. 2020;17:100341.
   Web of Science ®Google Scholar
• Ma Y, Wang M, Li W, et al. Live cell imaging of single genomic loci with quantum dot-labeled TALEs. Nat Commun. 2017;8(1):15318–15318.
   PubMedGoogle Scholar
• Li Y, Ma P, Tao Q, et al. Magnetic graphene quantum dots facilitate closed-tube one-step detection of SARS-CoV-2 with ultra-low field NMR relaxometry. Sens Actuators B Chem. 2021;337:129786.
   PubMed Web of Science ®Google Scholar
• Xue Y, Liu C, Andrews G, et al. Recent advances in carbon quantum dots for virus detection, as well as inhibition and treatment of viral infection. Nano Convergence. 2022;9(1):1–31.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Park J-H, Hayakawa K. Therapeutic use of extracellular mitochondria in CNS injury and disease. Exp Neurol. 2020;324:113114.
   PubMed Web of Science ®Google Scholar
• Lu S, Guo S, Xu P, et al. Hydrothermal synthesis of nitrogen-doped carbon dots with real-time live-cell imaging and blood–brain barrier penetration capabilities. Int J Nanomed. 2016;11:6325–6336.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Mintz KJ, Cheng L, et al. Direct conjugation of distinct carbon dots as lego-like building blocks for the assembly of versatile drug nanocarriers. J Colloid Interface Sci. 2020;576:412–425.
   PubMed Web of Science ®Google Scholar
• Niu Y, Tan H, Li X, et al. Protein–carbon dot nanohybrid-based early blood–brain barrier damage theranostics. ACS Appl Mater Interfaces. 2020;12(3):3445–3452.
   PubMed Web of Science ®Google Scholar
• Mintz KJ, Mercado G, Zhou Y, et al. Tryptophan carbon dots and their ability to cross the blood-brain barrier. Colloids Surf B Biointerfaces. 2019;176:488–493.
   PubMed Web of Science ®Google Scholar
• Gao L, Zhao X, Wang J, et al. Multiple functionalized carbon quantum dots for targeting glioma and tissue imaging. Opt Mater. 2018;75:764–769.
   Web of Science ®Google Scholar
• Li S, Amat D, Peng Z, et al. Transferrin conjugated nontoxic carbon dots for doxorubicin delivery to target pediatric brain tumor cells. Nanoscale. 2016;8(37):16662–16669.
   PubMed Web of Science ®Google Scholar
• Hettiarachchi SD, Graham RM, Mintz KJ, et al. Triple conjugated carbon dots as a nano-drug delivery model for glioblastoma brain tumors. Nanoscale. 2019;11(13):6192–6205.
   PubMed Web of Science ®Google Scholar
• Zhang W, Sigdel G, Mintz KJ, et al. Carbon dots: a future blood–brain barrier penetrating nanomedicine and drug nanocarrier. Int J Nanomedicine. 2021;16:5003–5016.
   PubMed Web of Science ®Google Scholar
• Sun LJ, Qu L, Yang R, et al. Cysteamine functionalized MoS2 quantum dots inhibit amyloid aggregation. Int J Biol Macromol. 2019;128:870–876. May 1
   PubMed Web of Science ®Google Scholar
• Tang M, Pi J, Long Y, et al. Quantum dots-based sandwich immunoassay for sensitive detection of alzheimer’s disease-related Aβ1–42. Spectrochim Acta A Mol Biomol Spectrosc. 2018;201:82–87.
   PubMed Web of Science ®Google Scholar
• Kim D, Yoo JM, Hwang H, et al. Graphene quantum dots prevent α-synucleinopathy in parkinson’s disease. Nat Nanotechnol. 2018;13(9):812–818.
   PubMed Web of Science ®Google Scholar
• Wang C, Yang F, Tang Y, et al. Graphene quantum dots nanosensor derived from 3D nanomesh graphene frameworks and its application for fluorescent sensing of Cu2+ in rat brain. Sens Actuat B: Chem. 2018;258:672–681.
   Web of Science ®Google Scholar
• Cai Q, Wang L, Deng G, et al. Systemic delivery to Central nervous system by engineered PLGA nanoparticles. Am J Transl Res. 2016;8(2):749–764.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Liyanage PY, Devadoss D, et al. Nontoxic amphiphilic carbon dots as promising drug nanocarriers across the blood–brain barrier and inhibitors of β-amyloid. Nanoscale. 2019;11(46):22387–22397.
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574.
   PubMed Web of Science ®Google Scholar